Octarine bio and ginkgo bioworks announce partnership to produce natural colors

Copenhagen, denmark and boston , may 9, 2023 /prnewswire/ -- octarine bio, a synthetic biology company developing new sustainable bio-based ingredients, and ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a multi-stage partnership focused on compounds in the tryptophan pathway, with the objective of engineering a strain for producing violacein and its derivatives, a naturally occurring bis-indole pigment with potent bioactive properties including anti-microbial, anti-oxidant, and uv protective properties. although initially focused on violacein, the collaboration has the potential to expand to other tryptophan-derived compounds, each with their own unique applications.
DNA Ratings Summary
DNA Quant Ranking